Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07560969 · ClinicalTrials.gov registry record · NA
Addressing Food Access and Physical Activity to Improve Diabetes Prevention Outcomes Among Underserved African Americans
A NA study, sponsored by University of Missouri, Kansas City.
- Not yet
- Registry status
- NA
- Development phase
- 408
- Enrollment target
NCT07560969: Clinical Trial NA study, sponsored by University of Missouri, Kansas City.
NCT07560969 is a NA study that has not yet begun recruiting, run by University of Missouri, Kansas City. The registered enrollment target is 408 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07560969, a NA study, has not yet begun recruiting, sponsored by University of Missouri, Kansas City.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 408 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if an enhanced, culturally, socially, and structurally tailored Diabetes Prevention Program (E-DPP) can improve weight loss and related diabetes risk factors in African American adults with prediabetes living in low-income, socially vulnerable communities. The main questions it aims to answer are: * Does the enhanced DPP (E-DPP) lead to greater percent weight loss at 6 and 12 months compared to the standard culturally tailored DPP (S-DPP)? * How do social determinants (e.g., food insecurity, stigma, access to resources) influence weight loss and engagement in lifestyle behaviors? Researchers will compare a standard culturally tailored DPP (S-DPP) to an enhanced DPP (E-DPP) to see if improving access to healthy food, physical activity, and community resources increases weight loss and improves diabetes-related outcomes. Participants will 1. Attend DPP sessions delivered in community settings (e.g., churches) 2. Receive lifestyle education focused on diet, physical activity, and weight loss 3. Engage in physical activity (including in-class exercise sessions \[E-DPP only\] and community-based options) 4. Receive support for healthy eating, including food deliveries (\[E-DPP only\]), food selection guidance, and referrals to food assistance programs 5. Receive information and support for accessing community resources for food and physical activity
Primary Outcome
Percent weight loss measured as percent change in weight (in pounds) from baseline at 6 and 12 months
Interventions
- BEHAVIORAL Culturally-tailored, enhanced adaption of Diabetes Prevention Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 408 participants |
| Start Date | 2027-01-04 |
| Est. Completion | 2031-02-28 |
| Phase | NA |
What is known before NCT07560969 opens enrollment
NCT07560969 is an interventional study that assigns participants to a tested intervention. The registered 408 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 1 intervention - of which Culturally-tailored, enhanced adaption of Diabetes Prevention Program is the first listed.
NCT07560969 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07560969 about?
NCT07560969 is a clinical study titled "Addressing Food Access and Physical Activity to Improve Diabetes Prevention Outcomes Among Underserved African Americans". The goal of this clinical trial is to learn if an enhanced, culturally, socially, and structurally tailored Diabetes Prevention Program (E-DPP) can improve weight loss and related diabetes risk factors in African American adults with prediabetes living in low-income, socially vulnerable communities....
What is the current status of trial NCT07560969?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 408 participants. The study started on 2027-01-04. Estimated completion is 2031-02-28.
What interventions are being tested in trial NCT07560969?
The interventions under investigation include: Culturally-tailored, enhanced adaption of Diabetes Prevention Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07560969?
This trial is sponsored by University of Missouri, Kansas City, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07560969's enrollment target sits among peer trials
408 243rd of 2000 higher than 1,758 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04835428 · 408 participants · NA
STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures
- NCT05836324 · 408 participants · Phase 1
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
- NCT05863195 · 408 participants · Phase 3
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- NCT06612268 · 408 participants · Phase 3
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI